Psilocybin, the psychoactive compound found in magic mushrooms, has gained significant attention in California due to its potential therapeutic benefits and growing scientific research. In recent years, the conversation surrounding the legal and medical use of psychedelics has intensified, particularly in the context of mental health treatment. California, known for being at the forefront of health and wellness trends, has become a hub for discussions and research on psilocybin therapy.
In this comprehensive guide, we will explore the current legal status of psilocybin in California, review ongoing legislative efforts to change its classification, and discuss the growing interest in its medical and therapeutic applications. Additionally, we’ll examine the legal pathways for accessing psilocybin and what the future might hold for the substance in California. By the end, you’ll have a detailed understanding of the landscape of psilocybin in the state and how it may affect you.
What is Psilocybin (“Magic Mushrooms”)?
Psilocybin is a naturally occurring psychedelic compound found in over 200 species of fungi, primarily from the genus Psilocybe. When ingested, psilocybin is metabolized into psilocin, which binds to serotonin 5-HT2A receptors in the brain, inducing altered states of perception, mood, and cognition. Psilocybin’s effects are linked to increased neural plasticity and modulation of the brain’s default mode network (DMN), which plays a crucial role in self-referential thoughts and cognition. These mechanisms are thought to underlie psilocybin’s therapeutic potential in treating mental health conditions such as depression, anxiety, and PTSD.
, for which psilocybin has been classified as a breakthrough therapy by the US Food & Drug Administration (FDA). Studies have demonstrated that psilocybin, when administered in a controlled setting, can lead to profound reductions in depressive symptoms after just one or two sessions. A notable trial conducted by Johns Hopkins University found that psilocybin, combined with supportive therapy, resulted in significant improvements in depressive symptoms, with many patients reporting long-lasting relief.
Psilocybin’s mechanism of action involves acting as a serotonin receptor agonist, particularly on the 5-HT2A receptors. This interaction is thought to increase neural connectivity, disrupt the brain’s default mode network (often linked to ruminative thinking in depression), and promote emotional and cognitive flexibility. These effects can potentially explain why patients often experience a sense of renewal and emotional clarity following psilocybin-assisted therapy. In addition to depression and anxiety, psilocybin therapy is being investigated for its potential in treating post-traumatic stress disorder (PTSD) and substance use disorders. Early trials have shown promising results in helping individuals confront trauma and break patterns of addiction, particularly in smoking cessation and alcohol dependency. While these findings are encouraging, proper screening, medical supervision, and post-session integration remain essential to ensure the safety and efficacy of psilocybin therapy.
All of the retreats and sessions at Odyssey are science and evidence-based, designed to mitigate any risk and maximize therapeutic benefits. Learn more here.
Read: Psilocybin Therapy for Depression and Psilocybin Therapy for Obsessive-Compulsive Disorder (OCD)
Ongoing Research
California is at the forefront of psilocybin research, with numerous studies underway at the University of California–San Francisco, the University of California–Berkeley, and the California Center for Psychedelic Therapy, among other institutions. These trials cover a wide range of applications, including treatment-resistant depression, chronic low back pain, Parkinson’s Disease, palliative care, bipolar disorder, anorexia, and more.
One particularly interesting study compares the physiological and psychological effects of psilocin and psilocybin in healthy adults aged 25-50. This research could provide valuable insights into the differences between these two related compounds and their potential therapeutic uses.
The ongoing research in California is contributing to a rapidly expanding body of evidence that supports psilocybin’s potential as a transformative mental health treatment. By exploring both physiological and psychological effects, studies aim to refine our understanding of how psilocybin and related compounds like psilocin can be best utilized in clinical settings. As these investigations progress, they are shaping the future of therapeutic practices, particularly by addressing conditions where conventional therapies have not been effective. California’s research efforts are positioned to play a pivotal role in establishing new therapeutic frameworks, potentially paving the way for psilocybin’s broader acceptance in mainstream medical treatments and expanding access to innovative mental health care solutions.
Read: The Safety of Psilocybin Therapy
Conclusion
California’s journey toward psilocybin reform has seen both progress and setbacks. While cities like Oakland and San Francisco have decriminalized the personal use and possession of certain psychedelics, the broader state-level effort faced a significant roadblock with the veto of Senate Bill 58 (SB-58) by Governor Gavin Newsom in October 2023. The bill, which aimed to decriminalize psilocybin, DMT, ibogaine, and mescaline, passed both chambers of the legislature but was ultimately rejected due to concerns over implementation and public health infrastructure. Newsom expressed interest in further research and a regulated therapeutic model rather than broad decriminalization, signaling that future efforts may need to align more closely with a medicalized approach similar to Oregon’s psilocybin services program.
At the local level, decriminalization efforts continue to expand. Cities such as Oakland and San Francisco have adopted measures that deprioritize law enforcement actions related to the personal use of psychedelics. While these policies do not equate to full legalization, they reflect a shifting perspective among policymakers and the public. Decriminalization at the municipal level serves as an important testing ground for broader reform efforts, providing insight into the societal impacts of reduced criminal penalties for psychedelic substances.
For now, Californians interested in psilocybin therapy must look to decriminalized local jurisdictions or pursue therapeutic sessions in states where psilocybin is fully regulated and legal, such as Oregon and Colorado.